ReviewCurrent opinion in infectious diseases2010
Advances in Rift Valley fever research: insights for disease prevention.
Review in Current opinion in infectious diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Research trends in Rift Valley fever virus: a bibliometric analysis from 1936 to 2024.Frontiers in veterinary science · 2025Pooled it
- Rift Valley Fever at Europe's Risk Frontier: Climate, Vectors, and One Health Preparedness.Veterinary sciences · 2026Review
- Heterogeneity of Rift Valley fever virus transmission potential across livestock hosts, quantified through a model-based analysis of host viral load and vector infection.PLoS computational biology · 2022Article
- Rift Valley Fever: Important Considerations for Risk Mitigation and Future Outbreaks.Tropical medicine and infectious disease · 2020Review
- Editorial: Emerging Arboviruses.Frontiers in veterinary science · 2020Article
- Evaluation of an Indirect Enzyme-Linked Immunosorbent Assay Based on Recombinant Baculovirus-Expressed Rift Valley Fever Virus Nucleoprotein as the Diagnostic Antigen.Journal of clinical microbiology · 2019Article
- The influence of raw milk exposures on Rift Valley fever virus transmission.PLoS neglected tropical diseases · 2019Article
- Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania.The Onderstepoort journal of veterinary research · 2019Article
- Participatory survey of Rift Valley fever in nomadic pastoral communities of North-central Nigeria: The associated risk pathways and factors.PLoS neglected tropical diseases · 2018Article
- Environmental limits of Rift Valley fever revealed using ecoepidemiological mechanistic models.Proceedings of the National Academy of Sciences of the United States of America · 2018Article
- Translating Predictions of Zoonotic Viruses for Policymakers.EcoHealth · 2018Article
- Current Status of Rift Valley Fever Vaccine Development.Vaccines · 2017Review
- Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.Journal of virology · 2015Article
- The role of the IKK complex in viral infections.Pathogens and disease · 2014Review
- Epidemiologic Investigations into Outbreaks of Rift Valley Fever in Humans, South Africa, 2008-2011.Emerging infectious diseases · 2013Article
- Towards a better understanding of Rift Valley fever epidemiology in the south-west of the Indian Ocean.Veterinary research · 2013Review
- Rift Valley fever risk map model and seroprevalence in selected wild ungulates and camels from Kenya.PloS one · 2013Article
- Curcumin inhibits Rift Valley fever virus replication in human cells.The Journal of biological chemistry · 2012Article
- Characterization of wild-type and alternate transcription termination signals in the Rift Valley fever virus genome.Journal of virology · 2011Article
- The 2007 Rift Valley fever outbreak in Sudan.PLoS neglected tropical diseases · 2011Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purpose of reviewThe purpose was to review recent research on Rift Valley fever virus (RVFV) infection, encompassing four main areas: epidemiology and outbreak prediction, viral pathogenesis, human diagnostics and therapeutics, and vaccine and therapeutic candidates. RECENT
findingsRVFV continues to extend its range in Africa and the Middle East. Better definition of RVFV-related clinical syndromes and human risk factors for severe disease, combined with early-warning systems based on remote-sensing, simplified rapid diagnostics, and tele-epidemiology, hold promise for earlier deployment of effective outbreak control measures. Advances in understanding of viral replication pathways and host cell-related pathogenesis suggest means for antiviral therapeutics and for more effective vaccination strategies based on genetically engineered virus strains or subunit vaccines. SUMMARY: RVFV is a significant health and economic burden in many areas of Africa, and remains a serious threat to other parts of the world. Development of more effective methods for RVFV outbreak prevention and control remains a global health priority.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.